Literature DB >> 19385809

Education level, primary language, and comprehension of the informed consent process.

Peter E Breese1, William J Burman, Stefan Goldberg, Stephen E Weis.   

Abstract

TO OBTAIN INFORMATION ON HOW PERSONS from diverse backgrounds experience the informed consent process, we surveyed adults with a wide variety of educational levels and different primary languages (English, Spanish, or Vietnamese) who had recently enrolled in a study requiring written informed consent. Of the 100 participants, 62 were non-White, 43 had less than a high school education, and 60 had a primary language other than English. The median score for comprehension was 62% (IQR 50-76%); the median satisfaction score was 86% (IQR 71-100%). In multivariate analysis, only educational level was significantly associated with comprehension and satisfaction with the informed consent process (p < 0.001). Comprehension and satisfaction with the informed consent process were markedly lower among persons with lower educational levels.

Entities:  

Year:  2007        PMID: 19385809     DOI: 10.1525/jer.2007.2.4.69

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  14 in total

1.  Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment.

Authors:  D Lamunu; K N Chapman; P Nsubuga; G Muzanyi; Y Mulumba; M A Mugerwa; S Goldberg; L Bozeman; M Engle; J Saukkonen; S Mastranunzio; H Mayanja-Kizza; J L Johnson
Journal:  Int J Tuberc Lung Dis       Date:  2012-04       Impact factor: 2.373

Review 2.  Research in Emergency and Critical Care Settings: Debates, Obstacles and Solutions.

Authors:  Ayman El-Menyar; Mohammad Asim; Rifat Latifi; Hassan Al-Thani
Journal:  Sci Eng Ethics       Date:  2015-11-24       Impact factor: 3.525

3.  Improving Research Literacy in Diverse Minority Populations with a Novel Communication Tool.

Authors:  Melissa A Simon; Rodney Haring; Elisa M Rodriguez; Evelyn González; Judith S Kaur; Marcie Kirschner; Laura Tom; Catherine A O'Brian; Mira L Katz
Journal:  J Cancer Educ       Date:  2019-12       Impact factor: 2.037

4.  Evaluation of the Informed Consent Process of a Multicenter Tuberculosis Treatment Trial.

Authors:  Kimberley N Chapman; Eric Pevzner; Joan M Mangan; Peter Breese; Dorcas Lamunu; Robin Shrestha-Kuwahara; Joseph G Nakibali; Stefan V Goldberg
Journal:  AJOB Empir Bioeth       Date:  2015-02-19

5.  The Development of a Communication Tool to Facilitate the Cancer Trial Recruitment Process and Increase Research Literacy among Underrepresented Populations.

Authors:  Samantha Torres; Erika E de la Riva; Laura S Tom; Marla L Clayman; Chirisse Taylor; Xinqi Dong; Melissa A Simon
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

6.  Are there adverse consequences of quizzing during informed consent for HIV research?

Authors:  J Sugarman; A Corneli; D Donnell; T Y Liu; S Rose; D Celentano; B Jackson; A Aramrattana; L Wei; Y Shao; F Liping; R Baoling; B Dye; D Metzger
Journal:  J Med Ethics       Date:  2011-06-08       Impact factor: 2.903

7.  Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods.

Authors:  Amy L Corneli; James R Sorenson; Margaret E Bentley; Gail E Henderson; J Michael Bowling; Jacqueline Nkhoma; Agnes Moses; Cynthia Zulu; James Chilima; Yusuf Ahmed; Charles M Heilig; Denise J Jamieson; Charles van der Horst
Journal:  AIDS Behav       Date:  2012-02

8.  Factors related to voluntary parental decision-making in pediatric oncology.

Authors:  Victoria A Miller; Robert M Nelson
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

9.  Moving Forward on Consent Practices in Australia.

Authors:  Rebekah E McWhirter; Lisa Eckstein
Journal:  J Bioeth Inq       Date:  2018-03-12       Impact factor: 1.352

10.  Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study.

Authors:  Andrew Schumacher; William M Sikov; Matthew I Quesenberry; Howard Safran; Humera Khurshid; Kristen M Mitchell; Adam J Olszewski
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.